Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the expansion of its Board of Directors with the addition of Linda Niessen, D.M.D., M.P.H., M.P.P. The addition of Dr. Niessen brings the number of board members to four.
Dr. Niessen has enjoyed a distinguished career within the professional dental community, currently serving as Dean and Professor at the Nova Southeastern University College of Dental Medicine in Fort Lauderdale, Florida. Nova Southeastern University College of Dental Medicine is the only dental school in South Florida and was the first private dental school in Florida. She has also served as a professor at Baylor College of Dentistry, Texas A&M University in Dallas from 1991 to 2013. In addition to her academic career, Dr. Niessen held executive positions at DENTSPLY International, a leading manufacturer and distributor of dental and other consumable medical device products, including most recently as Vice President, Chief Clinical Officer and prior as DENTSPLY’s Vice President, Clinical Education.
Dr. Niessen began her career at the U.S. Public Health Service Indian Hospital in Talihina, Oklahoma working with the Choctaw Nation of Oklahoma. She held a series of esteemed leadership positions, serving the dental community as President of the American Association of Women Dentists, the American Association of Public Health Dentistry and the Friends of the National Institute of Dental Craniofacial Research. She initiated several geriatric dental fellowship programs working with geriatric medicine physicians and started two dental public health residency programs. Her research has focused on oral disease patterns in older adults and health policy and financing issues for older adults.
Dr. Niessen received her B.A. degree from the University of New Mexico and her D.M.D. degree from the Harvard School of Dental Medicine. Additionally, Dr. Niessen received a M.P.H. degree from Harvard School of Public Health, a Certificate in Dental Public Health from Harvard School of Dental Medicine and a M.P.P. degree from the John F. Kennedy School of Government, Harvard University.
“We are thrilled to welcome Linda, an esteemed dental professional and educator, to our Board of Directors,” said Matthew Kim, Founder, Chairman and CEO of Vigilant Biosciences, Inc. “Her background and accomplishments are impressive and will bring enormous value to Vigilant Biosciences. Additionally, Dr. Niessen’s leadership roles and extensive knowledge in this space will be important as we continue to advance our OncAlert™ Oral Cancer product line towards commercialization.”
About Vigilant Biosciences, Inc.
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Vigilant’s OncAlert Oral Cancer product line includes rapid and lab-based products that are simple, accurate and cost-effective, and empower healthcare practitioners to improve lives through earlier intervention. The OncAlert Oral Cancer product line is not yet available for sale in the U.S. For more information, visit www.vigilantbiosciences.com.